Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check Foxchase.org for updates and monitor myTempleHealth for changes to scheduled appointments.
Dylane Wineland, MS, LCGC
Treatment Philosophy
As a cancer genetic counselor, I strive to empower individuals and their families with the knowledge and support needed to make informed decisions about genetic testing and managing their cancer risk. I recognize the emotional impact of a cancer diagnosis and hope to educate and guide with empathy and a personalized approach to hereditary cancer risk assessment. Working at Fox Chase offers a unique opportunity to work collaboratively with the rest of the healthcare team to ensure comprehensive and integrative care. I encourage active participation in decision-making to empower individuals to take control of their healthcare journey and hope to offer resources and support during the process.
Educational Background
- Master of Science in Genetic Counseling, Arcadia University, August 2018 –May 2020
- Bachelor of Science in Biology, Genetics, and Biotechnology track Minor in Psychology University of Iowa, August 2012 – May 2016
Certifications
- Certified Genetic Counselor, American Board of Genetic Counseling (ABGC)
- Licensed Genetic Counseling in Pennsylvania and New Jersey
Memberships
- National Society of Genetic Counselors (NSGC)
- Collaborative Group of the Americas Inherited Gastrointestinal Cancer (CGA-IGC
Selected Publications
Wineland, D., Le, A. N., Hausler, R., Kelly, G., Barrett, E., Desai, H., Wubbenhorst, B., Pluta, J., Bastian, P., Symecko, H., D'Andrea, K., Doucette, A., Gabriel, P., Reiss, K. A., Nayak, A., Feldman, M., Domchek, S. M., Nathanson, K. L., Maxwell, K. N., Regeneron Genetics Center, … Penn Medicine Biobank (2023). Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers. JCO precision oncology, 7, e2300036. https://doi.org/10.1200/PO.23.00036
Talbot DE, Vormezeele BJ, Kimble GC, et al. Prostaglandins limit nuclear actin to control nucleolar function during oogenesis. Front Cell Dev Biol. 2023;11:1072456. Published 2023 Feb 17. doi:10.3389/fcell.2023.1072456
Wineland, D. M., Kelpsch, D. J. and Tootle, T. L. (2018), Multiple Pools of Nuclear Actin. The Anatomical Record., 301: 2014-2036. doi:10.1002/ar.23964
